TY  - GEN
AU  - Gresnigt,Mark S
AU  - Rekiki,Abdessalem
AU  - Rasid,Orhan
AU  - Savers,Amélie
AU  - Jouvion,Grégory
AU  - Dannaoui,Eric
AU  - Parlato,Marianna
AU  - Fitting,Catherine
AU  - Brock,Matthias
AU  - Cavaillon,Jean-Marc
AU  - van de Veerdonk,Frank L
AU  - Ibrahim-Granet,Oumaïma
TI  - Reducing hypoxia and inflammation during invasive pulmonary aspergillosis by targeting the Interleukin-1 receptor
SN  - 2045-2322
PY  - 2018///0515
KW  - Adrenal Cortex Hormones
KW  - adverse effects
KW  - Animals
KW  - Carbonic Anhydrase IX
KW  - metabolism
KW  - Cell Hypoxia
KW  - drug effects
KW  - Cytokines
KW  - Disease Models, Animal
KW  - Immunocompromised Host
KW  - Interleukin 1 Receptor Antagonist Protein
KW  - administration & dosage
KW  - Invasive Pulmonary Aspergillosis
KW  - drug therapy
KW  - Mice
KW  - Receptors, Interleukin-1
KW  - antagonists & inhibitors
KW  - Receptors, Interleukin-8B
KW  - deficiency
KW  - Treatment Outcome
N1  - Publication Type: Journal Article; Research Support, Non-U.S. Gov't
UR  - https://doi.org/10.1038/srep26490
ER  -